Buys
Open market- Shares
- Avg price
- Total value
Jessica Sachs - Chief Medical Officer at Cogent Biosciences, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- COGT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Jessica Sachs in Cogent Biosciences, Inc.
Sells
Open market- Shares
- -82,642
- Avg price
- $38.70
- Total value
- -$3,198,245
Net
Past year- Shares
- -82,642
- Share %
- -100%
- Total value
- -$3,198,245
Reported holdings for Jessica Sachs in Cogent Biosciences, Inc.
Form 4 holding
Chief Medical Officer
Cogent Biosciences, Inc.
- Security class
- Common Stock
- Shares / value
- 133,938
- Estimated value
- $5,183,400
- Report date
- 26 Dec 2025
- Price
- $38.70
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
Cogent Biosciences, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 65,000
- Estimated value
- Report date
- 17 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jessica Sachs in Cogent Biosciences, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.